The Vatican has invested more than twenty years in pharmaceutical companies that produce morning-after pill and an abortion pill. The Vatican investment manager held 20 million shares in the management of Swiss pharmaceuticals Novartis and Roche.
This was announced by the Italian businessman Libero Milone, who was the Vatican‘s auditor general from 2015 to 2017. The former senior financial controller of the Vatican came up with his unveiling in the programme Report of the Italian public broadcaster RAI 3.
According to Milone, the sensitive investment shows how the doctrine of the Roman Catholic Church in which abortion is rejected is hardly taken into account in financial matters. Pope Francis spoke out against the abortion law in his native Argentina at the end of last year.
Sold in 2016
When Milone’s office discovered the investment in the pharmaceutical company, it was reported to senior officials of the Vatican. Subsequently, the Novartis shares were sold in 2016.